Author:
Suzuki Yuzo,Miwa Seiichi,Shirai Masahiro,Ohba Hisano,Murakami Miho,Fujita Kaoru,Suda Takafumi,Nakamura Hirotoshi,Hayakawa Hiroshi,Chida Kingo
Subject
Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine
Reference26 articles.
1. Joint Statement of the American Thoracic Society (ATS), Center for Disease Control and Prevention, and Infectious Diseases Society of America;Treatment of tuberculosis;Am J Respir Crit Care Med,2003
2. Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis;East African/BMJ Research Council;Lancet,1973
3. A controlled trial of six months of chemotherapy in pulmonary tuberculosis: second report; results during the 24 months after the end of chemotherapy;British Thoracic Association;Am Rev Respir Dis,1982
4. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis;Mitchison;Am Rev Respir Dis,1986
5. An official ATS statement: hepatotoxicity of antituberculosis therapy;Am J Respir Crit Care Med,2006
Cited by
47 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献